Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Seton Pharmaceuticals, priced at $1.6931 per EA under NDC 13925053601. Its NADAC has been published 205 times since Aug 3, 2022.
FDA first approved this application on Aug 13, 2021. Its Orange Book therapeutic-equivalence code is AA.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE
butalbital, acetaminophen and caffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Seton PharmaceuticalsNDC
13925053601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA214087FDA Approved
8/13/2021
TE Code
AA
On Market Since
3/2/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 205 times since Aug 3, 2022, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6931 per EA |
|---|---|
| All-time high | $2.9064 (Nov 13, 2024) |
| All-time low | $1.6931 (Jun 17, 2026) |
| 52-week high | $2.3000 |
| 52-week low | $1.6931 |
| Median price | $2.5341 |
| Average price | $2.3990 |
| Largest weekly change | +37.8% (Jun 19, 2024) |
| Weeks tracked | 205 |
| Tracking since | Aug 3, 2022 |
1W
N/A
1M
N/A
3M
-2.1%
6M
-12.9%
1Y
-23.8%
3Y
-36.4%
5Y
N/A
All
-34.6%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Seton Pharmaceuticals, is $1.6931 per EA (NDC 13925053601), effective Jul 1, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has declined 34.6%. It has been tracked across 205 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Since Aug 3, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $1.6931 (Jun 17, 2026) to a high of $2.9064 (Nov 13, 2024), with a median of $2.5341 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 13925053601) is labeled by Seton Pharmaceuticals, and CMS classifies it as a generic product.